Your shopping cart is currently empty

LW-216 is a TrxR1 inhibitor that induces cell apoptosis (Apoptosis) and possesses antitumor activity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | LW-216 is a TrxR1 inhibitor that induces cell apoptosis (Apoptosis) and possesses antitumor activity. |
| In vitro | LW-216 (5-25 μM, 24 h) selectively decreases the TrxR1 protein levels in NCI-H460 and A549 cells, subsequently inducing apoptosis. |
| In vivo | LW-216 administered intravenously (8 mg/kg, once every two days for 18 days) effectively suppressed tumor growth in a xenograft mouse model employing NCI-H460 cells. This treatment regimen significantly reduced bioluminescence intensity and increased the levels of apoptosis-inducing proteins Bax and Cleaved Caspase-3. Concurrently, there was a noticeable reduction in the expression of the proliferation marker Ki67. |
| Molecular Weight | 485.57 |
| Formula | C30H31NO5 |
| Cas No. | 2146090-18-6 |
| Smiles | O=C1C=C(OC2=C(OCCCCN3CCCC3)C(OCC=4C=CC=CC4)=CC(O)=C12)C=5C=CC=CC5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.